A new research paper was published in , Volume 16, on March 21, 2025, titled "NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma." ...

A new research paper was published in Oncotarget, Volume 16, on March 21, 2025, titled “NSD2-epigenomic reprogramming and ...

Pancreatic cancer remains one of the most deadly malignancies, with nearly 52,000 deaths expected this year.  With limited therapeutic advances made i | Cancer ...

The study in the European Respiratory Journal used advanced spatial mapping techniques to compare healthy lung tissues and tissues from patients with fatal IPF. The researchers discovered that disease ...

Our findings suggest a role for NSD2 in maintaining MM cell identity, with potential implications for future therapeutic ...

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Early infection incidence in patients with multiple myeloma following treatment with cilta-cel infusion highlights the ...

The researchers discovered that disease-scarred lung tissue abounds in plasma cells – specialized immune cells that typically reside in bone marrow and produce antibodies. “What we found most striking ...

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Now, research ...